EZH2 and neoplasm: While Varambally et al.’s work showed that EZH2 inhibition resulted in reduced cell proliferation [55], a study conducted on AR-WT and AR-∆LBD tumor cells (CRPC cell lines) showed that JMJD3 inhibition by GSK-J4 also resulted in reducing PC cell proliferation [61].